Written by Antonia Di Lorenzo || 1st February 2022 || News analysis || Companies | FDA | North America United States
US tobacco giant Altria has announced that it will not invest any further in the vapour category for the foreseeable future.
The company said it cannot undertake any organic development in the category because of its agreement with Juul Labs, but it would not look to change its minority investment. ...
Are you already a subscriber? login here
Enjoy free subscription access
Get access to premium content that is normally only available for subscribers.
For the duration of a week, you can read our news analysis, identify market trends and understand upcoming changes in the industry, which will enable you to get ahead of your competitors.
Benefits of subscription plans:
- Stay informed of any legal and market change in the sector that impacts your organization
- Maximise resources by getting market and legal data analysis daily in one place
- Make smart decisions by understanding how the regulatory and market landscape evolves
- Anticipate risks in your decisions by monitoring regulatory changes that impact your organization